In contrast, the overall prevalence of IDH2 mutation was 1%, being most frequent in anaplastic oligodendrogliomas, oligodendrogliomas and cutaneous squamous cell carcinomas (<15%). This evidence concerns the gene IDH2 and cutaneous squamous cell carcinoma.